Viewing Study NCT06143306



Ignite Creation Date: 2024-05-06 @ 7:49 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06143306
Status: RECRUITING
Last Update Posted: 2024-03-21
First Post: 2023-08-21

Brief Title: Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
Sponsor: University of Minnesota
Organization: University of Minnesota

Study Overview

Official Title: Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The use of ISB in patients undergoing total shoulder arthroplasty TSA is the gold standard and results in significantly reduced pain scores and opioid use However patients still have pain and the majority require opioids postoperatively as the interscalene block ISB doesnt cover all of the dermatomes impacted during TSA A pectoserratus block typically provides coverage to additional dermatomes that are impacted during TSA Currently ISB is performed for every patient and perform a pectoserratus block to a portion of our patients undergoing TSA The purpose of the study is to determine if the addition of the pectoserratus block to the ISB will results in improvement in pain control and decrease in opioid use among patients undergoing TSA This is a randomized prospective controlled trial All patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty aged 18-85 will be considered eligible for the study Participants will be randomized to one of 2 treatment groups Group 1 will receive an ultrasound guided pectoserratus block with 25 mL of 025 bupivacaine Group 2 will be the control and receive an ultrasound guided pectoserratus block with 25 mL of saline The drug will be administered by the anesthesiologist in-charge of the participants care or an anesthesiologist who is a part of the study team
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None